Epididymis-specific lipocalin promoters.
- Author:
Kichiya SUZUKI
1
;
Xiuping YU
;
Pierre CHAURAND
;
Yoshihiko ARAKI
;
Jean-Jacques LAREYRE
;
Richard M CAPRIOLI
;
Marie-Claire ORGEBIN-CRIST
;
Robert J MATUSIK
Author Information
1. Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. kichiyasuzuki@mail.tains.tohoku.ac.jp
- Publication Type:Journal Article
- MeSH:
Animals;
Base Sequence;
Carrier Proteins;
genetics;
Epididymis;
physiology;
Hepatocyte Nuclear Factor 3-beta;
genetics;
Humans;
Lipocalins;
Male;
Mice;
Molecular Sequence Data;
Multigene Family;
Promoter Regions, Genetic;
Prostate;
physiology;
Receptors, Retinoic Acid;
genetics;
Retinol-Binding Proteins, Plasma
- From:
Asian Journal of Andrology
2007;9(4):515-521
- CountryChina
- Language:English
-
Abstract:
Our goal is to decipher which DNA sequences are required for tissue-specific expression of epididymal genes. At least 6 epididymis-specific lipocalin genes are known. These are differently regulated and regionalized in the epididymis. Lipocalin 5 (Lcn5 or mE-RABP) and Lipocalin 8 (Lcn8 or mEP17) are homologous genes belonging to the epididymis-specific lipocalin gene cluster. Both the 5 kb promoter fragment of the Lcn5 gene and the 5.3 kb promoter fragment of the Lcn8 gene can direct transgene expression in the epididymis (Lcn5 to the distal caput and Lcn8 to the initial segment), indicating that these promoter fragments contain important cis-regulatory element(s) for epididymis-specific gene expression. To define further the fragments regulating gene expression, the Lcn5 promoter was examined in transgenic mice and immortalized epididymal cell lines. After serial deletion, the 1.8 kb promoter fragment of the Lcn5 gene was sufficient for tissue-specific and region-specific gene expression in transgenic mice. Transient transfection analysis revealed that a transcription factor forkhead box A2 (Foxa2) interacts with androgen receptor and binds to the 100 bp fragment of the Lcn5 promoter between 1.2 kb and 1.3 kb and that Foxa2 expression inhibits androgen-dependent induction of the Lcn5 promoter activity. Immunohistochemistry indicated a restricted expression of Foxa2 in the epididymis where endogenous Lcn5 gene expression is suppressed and that the Foxa2 inhibition of the Lcn5 promoter is consistent with the lack of expression of Lcn5 in the corpus and cauda. Our approach provides a basic strategy for further analysis of the epididymal lipocalin gene regulation and flexible control of epididymal function.
